Pages

Scientific Board

Scientific Board

Prof. Dr. Bernd Wollscheid


Dr. Bernd Wollscheid

Prof. Dr. Bernd Wollscheid is a Principal Investigator and Head of the Biomedical Proteomics Platform at the Department of Health Sciences and Technology of Swiss Federal Institute of Technology in Zurich, Switzerland. After studying chemistry in Freiburg and Boston he obtained his PhD in Molecular Immunology from the Max-Planck Institute for Immunobiology. His postdoctoral research took him to the Institute of Systems Biology in Seattle where he developed and applied chemoproteomic technologies to elucidate cell surface protein biology. Now at the Institute for Molecular Systems Biology at ETH Zurich he developed a research program focusing on a Systems Biology understanding of the cell surface as a cellular signaling gateway.

Publication 16.9.2012: Direct identification of ligand-receptor interactions on living cells and tissues
Please find the LRC technology by: LRC-TriCEPS Services

Professor Dr. Ruedi Aebersold


Professor Dr. Ruedi Aebersold

Prof. Ruedi Aebersold is one of the pioneers in the field of proteomics. He obtained his Ph.D. in Cellular Biology at the Biocenter of the University of Basel in 1983. Since that time, he is a faculty member of the Universities of Washington and British Columbia, until 2000, when he co-founded the Institute for Systems Biology in Seattle. In 2004, he accepted a position as full professor at the Institute of Biotechnology at the Swiss Federal Institute of Technology (ETH) in Zurich, where in January 2005, his research group became the first integral part of the newly founded Institute of Molecular Systems Biology.

Publication 16.9.2012: Direct identification of ligand-receptor interactions on living cells and tissues
Please find the LRC technology by: LRC-TriCEPS  Services